Patrick Aebischer
Directeur/Membre du Conseil chez POLYPEPTIDE GROUP AG
Fortune : 4 M $ au 31/05/2024
Profil
Patrick Aebischer is the founder of Modex Therapeutics Ltd.
(founded in 1996), CytoTherapuetics, Inc. (founded in 1989), Amazentis SA (founded in 2007), and Vandria SA (founded in 2021).
He is currently the Chairman of Novartis Venture Fund, Vice Chairman of PolyPeptide Laboratories Holding (PPL) AB, Chairman of Arctos SA, Chairman of Arctos Medical AG, Vice Chairman of Geneva Science & Diplomacy Anticipator Foundation, Vice Chairman of PolyPeptide Group AG, Chairman of ArtTech Foundation, Independent Non-Executive Director of Logitech International SA, Independent Non-Executive Director of Nestlé SA, Director of Logitech, Inc., Director of Defitech Foundation, Director of Logitech SA, Director of Montreux Jazz Festival Foundation, Director of Verbier Festival, Director of Claude Nobs Foundation, and Member of the Governors Board of Jacobs University Bremen.
He is also a Senior Partner of NanoDimension Management Ltd., a Member of The Singapore Biomedical Sciences Intl Advisory Council, a Member of the Foundation Board of WYSS Center, and a Senior Partner of Nanodimension III Management Ltd.
In the past, he served as Chairman of Novartis BioVentures AG, Chairman-Biomaterials & Cellular Technology at Brown University (1984-1992), Vice Chairman of Lonza Group AG (2008-2020), Director of CSEM Centre Suisse d'Electronique et Microtechnique SA, Professor & Director-Brain Mind Institute at École Polytechnique Fédérale de Lausanne (2000-2017), Director of Nestle Health Science SA (2011-2015), Professor & Director-Surgical Division at Centre Hospitalier Universitaire Vaudois, Professor-Neurosciences at Swiss Federal Institute of Technology (2000-2016), and Member of the Foundation Board of Forum Mondial de L'Economie (2013-2016).
He holds a doctorate degree from the University of Geneva (1983).
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 14/09/2023 | 19 519 ( 0,01% ) | 2 M $ | 31/05/2024 | |
NESTLE S.A.
0,00% | 31/12/2023 | 17 046 ( 0,00% ) | 2 M $ | 31/05/2024 |
POLYPEPTIDE GROUP AG
0,04% | 31/12/2023 | 14 503 ( 0,04% ) | 536 940 $ | 31/05/2024 |
Postes actifs de Patrick Aebischer
| Sociétés | Poste | Début |
|---|---|---|
| LOGITECH INTERNATIONAL S.A. | Directeur/Membre du Conseil | 07/09/2016 |
| NESTLÉ S.A. | Directeur/Membre du Conseil | 16/04/2015 |
| POLYPEPTIDE GROUP AG | Directeur/Membre du Conseil | 01/01/2021 |
Arctos Medical AG
 Arctos Medical AG BiotechnologyHealth Technology Arctos Medical AG engages in the acquisition, development, holding, registration, management, disposal, and exploitation of intellectual property rights and similar assets in the medical sector. These include patents, trademarks, licenses, industrial property rights, and inventions. The company was founded on June 6, 2012 and is headquartered in Bern, Switzerland. | Président | 01/01/2019 |
| Geneva Science & Diplomacy Anticipator Foundation | Directeur/Membre du Conseil | 01/01/2019 |
| Nanodimension III Management Ltd. | Corporate Officer/Principal | 01/01/2017 |
| Montreux Jazz Festival Foundation | Directeur/Membre du Conseil | - |
PolyPeptide Laboratories Holding (PPL) AB
 PolyPeptide Laboratories Holding (PPL) AB Financial ConglomeratesFinance PolyPeptide Laboratories Holding (PPL) AB manufactures commercial therapeutic peptides. The firm offers polypeptide, custom peptide synthesis, peptide synthesis, and generic peptide. The company was founded in 1996 and is headquartered in Malmo, Sweden. | Directeur/Membre du Conseil | - |
Vandria SA
 Vandria SA Pharmaceuticals: MajorHealth Technology Vandria SA is a Swiss-based company that specializes in mitochondrial therapeutics. The company is based in Lausanne, Switzerland. The company is developing mitophagy inducers that rejuvenate cells to treat age-related and chronic diseases. Its lead program, VNA-318, is a brain-penetrant, patent-protected, mitophagy inducer that has shown to improve memory and learning and to have strong disease-modifying effects in models of neurodegenerative diseases such as Alzheimer's and Parkinson's disease. Vandria is also developing mitophagy-inducing small molecules to address muscle, lung, and liver diseases, as well as a separate program that targets ferroptosis. The company was founded by Patrick Aebischer, Chris Rinsch, and Johan Auwerx in 2021 and has raised $20.60m in venture finance. Klaus Dugi has been the CEO of the company since 2021. | Fondateur | - |
| ░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Patrick Aebischer
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░ ░░░░░░░░░ ░░ ░░░░░░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Patrick Aebischer
| University of Geneva | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| LONZA GROUP AG | Health Technology |
| LOGITECH INTERNATIONAL S.A. | Electronic Technology |
| NESTLÉ S.A. | Consumer Non-Durables |
| POLYPEPTIDE GROUP AG | Health Technology |
| Entreprise privées | 25 |
|---|---|
CSEM Centre Suisse d'Electronique et Microtechnique SA
 CSEM Centre Suisse d'Electronique et Microtechnique SA Miscellaneous Commercial ServicesCommercial Services CSEM Centre Suisse d'Electronique et Microtechnique SA provides applied research, technology and consulting services. The firm’s services include contract research and development, small series production, technology transfer, start-ups and ventures, alliance and partnerships, photovoltaics, microsystems, surface engineering and systems. The company was founded in 1984 and is headquartered in Neuchatel, Switzerland. | Commercial Services |
Nestle Health Science SA
 Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Nestle Health Science SA develops nutritional therapies. Its health management services include aging, brain health, chronic medical conditions, critical care and surgery, food allergy, gastro intestinal, metabolic diseases, and obesity pediatrics. The company was founded in 2011 and is headquartered in Vevey, Switzerland. | Health Technology |
Forum Mondial de L'Economie
 Forum Mondial de L'Economie Miscellaneous Commercial ServicesCommercial Services Forum Mondial de L'Economie engages in the foremost political, business and cultural organizations to shape global, regional and industry agendas. The company was founded by Klaus Schwab in 1971 and is headquartered in Cologny, Switzerland. | Commercial Services |
| The Singapore Biomedical Sciences Intl Advisory Council | |
Amazentis SA
 Amazentis SA Miscellaneous Commercial ServicesCommercial Services Amazentis SA is a Swiss innovative life science company that focuses on developing products targeting mitochondrial health for advanced nutrition. The company was founded in 2007 by Pierre Landolt, Patrick Aebischer, and Chris Rinsch, and it is currently based in Lausanne, Switzerland. The company has published its research on Mitopure™ Urolithin A in top peer-reviewed scientific journals, including Nature Medicine, Nature Metabolism, JAMA Network Open, and European Journal of Clinical Nutrition. Amazentis has a strategic partnership with Nestlé Health Science to expand the health applications of Mitopure™. Brian Ray has been the CEO of the company since 2023. | Commercial Services |
| WYSS Center | |
Logitech, Inc.
 Logitech, Inc. Electronics DistributorsDistribution Services Logitech, Inc. designs, manufactures, and markets cordless products for personal computers, gaming consoles, portable music players, and mobile phones. Its products include audio and video products, webcams, mice, trackballs, keyboards, speakers, headsets, interactive gaming devices, digital pens, and universal remote controls. The company was founded in 1981 and is headquartered in Newark, CA. | Distribution Services |
Logitech SA
 Logitech SA Electronics DistributorsDistribution Services Part of Logitech International SA, Logitech SA is a Swiss company that offers a range of award-winning products, including video conferencing solutions for small to large meeting rooms. The company is based in Romanel-sur-Morges, Switzerland. The company's products have been recognized for their design excellence, originality, and innovation by organizations such as Red Dot, Good Design, IF, and IDA. Customers can use an online tool to configure their meeting rooms with the right video conferencing solution. | Distribution Services |
| Modex Therapeutics Ltd. | Commercial Services |
| Verbier Festival | Miscellaneous |
| Arctos SA | |
PolyPeptide Laboratories Holding (PPL) AB
PolyPeptide Laboratories Holding (PPL) AB Financial ConglomeratesFinance PolyPeptide Laboratories Holding (PPL) AB manufactures commercial therapeutic peptides. The firm offers polypeptide, custom peptide synthesis, peptide synthesis, and generic peptide. The company was founded in 1996 and is headquartered in Malmo, Sweden. | Finance |
| Geneva Science & Diplomacy Anticipator Foundation | |
| Nanodimension III Management Ltd. | |
Novartis BioVenturesAG
 Novartis BioVenturesAG Investment ManagersFinance Part of Novartis AG, Novartis BioVenturesAG is an alternative investment manager. The company is based in Basel, Switzerland. | Finance |
| CytoTherapuetics, Inc. | Finance |
Novartis Venture Fund
 Novartis Venture Fund Investment ManagersFinance Novartis Venture Fund provides early stage venture capital to companies in Europe, North America and Asia. The fund's focus is on the development of novel therapeutics and platforms, therefore it focuses on such sectors as Biotechnology and Biopharma. The fund makes seed and early stage investments ranging up to USD 30 million per company over its life. The fund makes follow-on and co-investments. | Finance |
Arctos Medical AG
Arctos Medical AG BiotechnologyHealth Technology Arctos Medical AG engages in the acquisition, development, holding, registration, management, disposal, and exploitation of intellectual property rights and similar assets in the medical sector. These include patents, trademarks, licenses, industrial property rights, and inventions. The company was founded on June 6, 2012 and is headquartered in Bern, Switzerland. | Health Technology |
| Montreux Jazz Festival Foundation | Miscellaneous |
Vandria SA
Vandria SA Pharmaceuticals: MajorHealth Technology Vandria SA is a Swiss-based company that specializes in mitochondrial therapeutics. The company is based in Lausanne, Switzerland. The company is developing mitophagy inducers that rejuvenate cells to treat age-related and chronic diseases. Its lead program, VNA-318, is a brain-penetrant, patent-protected, mitophagy inducer that has shown to improve memory and learning and to have strong disease-modifying effects in models of neurodegenerative diseases such as Alzheimer's and Parkinson's disease. Vandria is also developing mitophagy-inducing small molecules to address muscle, lung, and liver diseases, as well as a separate program that targets ferroptosis. The company was founded by Patrick Aebischer, Chris Rinsch, and Johan Auwerx in 2021 and has raised $20.60m in venture finance. Klaus Dugi has been the CEO of the company since 2021. | Health Technology |
| ArtTech Foundation | |
| Defitech Foundation | |
| Claude Nobs Foundation | |
Centre Hospitalier Universitaire Vaudois
 Centre Hospitalier Universitaire Vaudois Hospital/Nursing ManagementHealth Services Centre Hospitalier Universitaire Vaudois is a university hospital located in Lausanne, CH. The SwitzerlandUV is also a renowned center of medical education and research, collaborating with the Faculty of Biology and Medicine of the University of Lausanne and the Swiss Federal Institute of Technology in Lausanne (EPFL). It has 16 clinical and medico-technical departments and is known for its academic achievements in healthcare, research, and teaching. The vast campus in the lake region is home to these institutions. The CEO of the Swiss company is Nicolas Demartines. | Health Services |
NanoDimension Management Ltd.
 NanoDimension Management Ltd. Investment ManagersFinance NanoDimension Management Ltd is a venture capital firm founded in 2002 by Aymeric Sallin. The firm is headquartered in George Town. | Finance |
